Common use of Publications and Presentations Clause in Contracts

Publications and Presentations. The Parties acknowledge that scientific publications must be strictly monitored to prevent any adverse effect from premature publication or dissemination of results of the activities hereunder. Except as required by Applicable Laws, each Party agrees that it shall not publish or present, or permit to be published or presented, the results of the Research Program, the Development of a Candidate or the Commercialization of a Product, including, but not limited to, studies or clinical trials carried out by such Party as part of the Collaboration, without the prior review by and the approval of the JSC in accordance with Section 2.1. Each Party shall provide to the JSC the opportunity to review any of the submitting Party’s proposed abstracts, manuscripts or presentations (including information to be presented verbally) which relate to the Research Program, the Development of a Candidate or the Commercialization of a Product at least [*****] days prior to its intended presentation or submission for publication, and such submitting Party agrees, upon written request from the TSC within such [*****] day period, not to submit such abstract or manuscript for publication or to make such presentation until the other Party is given up to [*****] days from the date of such written request to seek appropriate patent protection for any material in such publication or presentation which the JSC reasonably believes is patentable. Once such abstracts, manuscripts or presentations have been reviewed by the JSC, the same abstracts, manuscripts or presentations do not have to be provided again to the JSC for review for a later submission for publication. Each Party also shall have the right to require that its Confidential Information that is disclosed in any such proposed publication or presentation be deleted prior to such publication or presentation. In any permitted publication or presentation by a Party, the other Party’s contribution shall be duly recognized, and co-authorship shall be determined in accordance with customary industry standards.

Publications and Presentations. The Parties acknowledge that scientific publications and presentations must be strictly monitored to prevent any adverse effect from premature publication or dissemination of results of the activities hereunder. Except Each Party agrees that, except as required by Applicable Laws, each Party agrees that it shall not publish or present, or permit to be published or presented, the results of the Research Program, the Development of a Candidate or the Commercialization of a Product, including, but not limited to, studies or clinical trials carried out by such Party as part of the Collaboration, without the prior review by and the approval of the JSC in accordance with Section 2.1[********]. Each Party shall provide to the JSC other Party the opportunity to review any each of the submitting Party’s proposed abstracts, manuscripts or presentations (including information to be presented verbally) which that relate to the Research Program, the Development of a Candidate or the Commercialization of a Product Program [********] at least [********] days prior to its intended presentation or submission for publication, and such submitting Party agrees, upon written request from the TSC other Party given within such [********] day period, not to submit such abstract or manuscript for publication or to make such presentation until the other Party is given up to [********] days from the date of such written request to seek appropriate patent protection for any material in such publication or presentation which the JSC that it reasonably believes is may be patentable. Further, AstraZeneca shall [********]. Once such abstractsan abstract, manuscripts manuscript or presentations have presentation has been reviewed and, in the case of any abstract, manuscript or presentation that relates to the Research Program, approved by the JSCa Party [********], the same abstractsabstract, manuscripts manuscript or presentations do presentation does not have to be provided again to the JSC other Party for review for a later submission for publication. Each Party also shall have the right to require that any of its Confidential Information that is disclosed in any such proposed publication or presentation be deleted prior to such publication or presentation. In any permitted publication or presentation by a Party, the other Party’s contribution shall be duly recognized, and co-authorship shall be determined in accordance with customary industry standards. All such abstracts, manuscripts and presentations by or on behalf of Targacept shall [********]. Notwithstanding anything in this Section 7.3 to the contrary, Targacept shall [********] publication in connection with the Ongoing Ispronicline Trial; provided that Targacept shall (a) coordinate its activities in connection therewith with AstraZeneca in good faith and (b) permit AstraZeneca to review and comment on any such publication.

Publications and Presentations. The Parties acknowledge that scientific publications and presentations must be strictly monitored to prevent any adverse effect from premature publication or dissemination of results of the activities hereunder. Except Each Party agrees that, except as required by Applicable Laws, each Party agrees that it shall not publish or present, or permit to be published or presented, the results of the Research Program, the Program or any Development of a Candidate or the Commercialization of a Product, including, but not limited to, studies or clinical trials carried out by such Party as part of the Collaboration, Program without the prior review by and the approval of the JSC in accordance with Section 2.1other Party. Each Party shall provide to the JSC other Party the opportunity to review any each of the submitting Party’s proposed abstracts, manuscripts or presentations (including including, without limitation, information to be presented verbally) which that relate to the Research Program, the Program or any Development of a Candidate or the Commercialization of a Product Program at least [*****] days prior to its intended presentation or submission for publication, and such submitting Party agrees, upon written request from the TSC other Party given within such [*****] day period, not to submit such abstract or manuscript for publication or to make such presentation until the other Party is given up to [*****] Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Company’s application requesting confidential treatment under Rule 406 of the Securities Act. days from the date of such written request to seek appropriate patent protection for any material in such publication or presentation which the JSC that it reasonably believes is may be patentable. Once such abstracts, manuscripts or presentations have been reviewed and approved by the JSCeach Party, the same abstracts, manuscripts or presentations do not have to be provided again to the JSC other Party for review for a later submission for publication. Each Party also shall have the right to require that any of its Confidential Information that is disclosed in any such proposed publication or presentation be deleted prior to such publication or presentation. In any permitted publication or presentation by a Party, the other Party’s contribution shall be duly recognized, and co-authorship shall be determined in accordance with customary industry standards. Each Party (i) expressly acknowledges that the other Party’s business may be substantially dependent on its ability to publish results in scientific journals, presentation at scientific conferences and meetings and (ii) agrees that it shall not unreasonably withhold, condition or delay its consent to any request by the other Party to publish results of the Research Program or any Development Program in accordance with its internal publication guidelines.

Publications and Presentations. The Parties acknowledge that scientific publications and presentations must be strictly monitored to prevent any adverse effect from premature publication or dissemination of results of the activities hereunder. Except Each Party agrees that, except as required by Applicable Laws, each Party agrees that it shall not publish or present, or permit to be published or presented, the results of the Research Program, the Development of a Candidate or the Commercialization of a Product, including, but not limited to, studies or clinical trials carried out by such Party as part of the Collaboration, Program without the prior review by and the approval of the JSC in accordance with Section 2.1other Party. Each Party shall provide to the JSC other Party the opportunity to review any each of the submitting Party’s proposed abstracts, manuscripts or presentations (including including, without limitation, information to be presented verbally) which that relate to the Research Program, the Development of a Candidate or the Commercialization of a Product Program at least [*****] days prior to its intended presentation or submission for publication, and such submitting Party agrees, upon written request from the TSC other Party given within such [*****] ]day period, not to submit such abstract or manuscript for publication or to make such presentation until the other Party is given up to [*****] days from the date of such written request to seek appropriate patent protection for any material in such publication or presentation which the JSC that it reasonably believes is may be patentable. Once such abstracts, manuscripts or presentations have been reviewed and approved by the JSCeach Party, the same subject matter disclosed in such abstracts, manuscripts Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Company's application requesting confidential treatment under Rule 406 of the Securities Act. 41 or presentations do does not have to be provided again to the JSC other Party for review for a later submission for publication. Each Party also shall have the right to require that any of its Confidential Information that is disclosed in any such proposed publication or presentation be deleted prior to such publication or presentation. In any permitted publication or presentation by a Party, the other Party’s contribution shall be duly recognized, and co-authorship shall be determined in accordance with customary industry standards. Subject to the foregoing obligations of this Section 6.3, TAKEDA may use the results of the Research Program for the purpose and to the extent necessary to develop and commercialise Products in accordance with this Agreement. Notwithstanding the foregoing, TAKEDA shall exclusively control all scientific publications and presentations that contain any data relating to an Optimized Lead Compound or Product. ARCHEMIX agrees that, except as required by Applicable Laws, it shall not publish or present, or permit to be published or presented, any data arising out of the Development Program relating to an Optimized Lead Compound or Product without the prior review and express written approval of TAKEDA which may be withheld at TAKEDA’s sole discretion.

Publications and Presentations. The Parties acknowledge that scientific publications and presentations must be strictly monitored to prevent any adverse effect from premature publication or dissemination of results of the activities hereunder. Except Each Party agrees that, except as required by Applicable Laws, each Party agrees that it shall not publish or present, or permit to be published or presented, the results of the Research Program, the Program or any Development of a Candidate or the Commercialization of a Product, including, but not limited to, studies or clinical trials carried out by such Party as part of the Collaboration, Program without the prior review by and the approval of the JSC in accordance with Section 2.1other Party. Each Party shall provide to the JSC other Party the opportunity to review any each of the submitting Party’s proposed abstracts, manuscripts or presentations (including including, without limitation, information to be presented verbally) which that relate to the Research Program, the Program or any Development of a Candidate or the Commercialization of a Product Program at least [*****] days prior to its intended presentation or submission for publication, and such submitting Party agrees, upon written request from the TSC other Party given within such [*****] day period, not to submit such abstract or manuscript for publication or to make such presentation until the other Party is given up to [*****] days from the date of such written request to seek appropriate patent protection for any material in such publication or presentation which the JSC that it reasonably believes is may be patentable. Once such abstracts, manuscripts or presentations have been reviewed and approved by the JSCeach Party, the same abstracts, manuscripts or presentations do not have to be provided again to the JSC other Party for review for a later submission for publication. Each Party also shall have the right to require that any of its Confidential Information that is disclosed in any such proposed publication or presentation be deleted prior to such publication or presentation. In any permitted publication or presentation by a Party, the other Party’s contribution shall be duly recognized, and co-authorship shall be determined in accordance with customary industry standards. Each Party (i) expressly acknowledges that the other Party’s business may be substantially dependent on its ability to publish results in scientific journals, presentation at scientific conferences and meetings and (ii) agrees that it shall not unreasonably withhold, condition or delay its consent to any request by the other Party to publish results of the Research Program or any Development Program in accordance with its internal publication guidelines.

Publications and Presentations. The Parties acknowledge that scientific publications must be strictly monitored to prevent any adverse effect from premature publication or dissemination of results of the activities hereunder. Except as required by Applicable Laws, each Party agrees that it shall not publish or present, or permit to be published or presented, the results of the Research Program, the Development of a Candidate or the Commercialization of a Product, including, but not limited to, studies or clinical trials carried out by such Party as part of Confidential materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote such omission. the Collaboration, without the prior review by and the approval of the JSC in accordance with Section 2.1. Each Party shall provide to the JSC the opportunity to review any of the submitting Party’s proposed abstracts, manuscripts or presentations (including information to be presented verbally) which relate to the Research Program, the Development of a Candidate or the Commercialization of a Product at least [*****] days prior to its intended presentation or submission for publication, and such submitting Party agrees, upon written request from the TSC within such [*****] day period, not to submit such abstract or manuscript for publication or to make such presentation until the other Party is given up to [*****] days from the date of such written request to seek appropriate patent protection for any material in such publication or presentation which the JSC reasonably believes is patentable. Once such abstracts, manuscripts or presentations have been reviewed by the JSC, the same abstracts, manuscripts or presentations do not have to be provided again to the JSC for review for a later submission for publication. Each Party also shall have the right to require that its Confidential Information that is disclosed in any such proposed publication or presentation be deleted prior to such publication or presentation. In any permitted publication or presentation by a Party, the other Party’s contribution shall be duly recognized, and co-authorship shall be determined in accordance with customary industry standards.

Publications and Presentations. The Parties acknowledge that scientific publications must be strictly monitored to prevent any adverse effect from premature publication or dissemination of results of the activities hereunder. Except as required by Applicable Laws, each Party agrees that it shall not publish or present, or permit to be published or presented, the results of the Research Program, the Development of a Candidate or the Commercialization of a Product, including, but not limited to, studies or clinical trials carried out by such Party as part of the Collaboration, without the prior review by and the approval of the JSC in accordance with Section 2.1. Each Party shall provide to the JSC the opportunity to review any of the submitting Party’s proposed abstracts, manuscripts or presentations (including information to be presented verbally) which relate to the Research Program, the Development of a Candidate or the Commercialization of a Product at least [*****] days prior to its intended presentation or submission for publication, and such submitting Party agrees, upon written request from the TSC within such [*****] day period, not to submit such abstract or manuscript for publication or to make such presentation until the other Party is given up to [*****] days from the date of such written request to seek appropriate patent protection for any material in such publication or presentation which the JSC reasonably believes is patentable. Once such abstracts, manuscripts or presentations have been reviewed by the JSC, the same abstracts, manuscripts or presentations do not have to be provided again to the JSC for review for a later submission for publication. Each Party also shall have the right to require that its Confidential Information that is disclosed in any such proposed publication or presentation be deleted prior to such publication or presentation. In any permitted publication or presentation by a Party, the other Party’s Confidential materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote such omission. contribution shall be duly recognized, and co-authorship shall be determined in accordance with customary industry standards.

Publications and Presentations. The Parties acknowledge that scientific publications and presentations must be strictly monitored to prevent any adverse effect from premature publication or dissemination of results of the activities hereunder. Except ImmunoGen agrees that, except as required by Applicable Laws, each Party agrees that it shall not publish or present, or permit to be published or presented, the results of the Research Program, the Development of a Candidate or the and Commercialization of a Product, including, but not limited Licensed Product to the extent such results refer to, studies derive from or clinical trials carried out by such Party as part of otherwise relate to the Collaboration, Licensed Intellectual Property without the prior review by and the approval of the JSC in accordance with Section 2.1Novartis. Each Party Novartis shall provide to the JSC ImmunoGen the opportunity to review any each of the submitting Party’s Novartis’ proposed abstracts, manuscripts or presentations (including including, without limitation, information to be presented verbally) which relate to the Research Program, the Development of a Candidate that contain ImmunoGen’s Confidential Information or the Commercialization of a Product disclose any unpatented Licensed Technology at least [*****] days prior to its intended presentation or submission for publication, and such submitting Party Novartis agrees, upon written request from the TSC ImmunoGen given within such [*****] day ]-day period, not to submit such abstract or manuscript for publication or to make such presentation until the other Party ImmunoGen is given up to [*****] days from the date of such written request to seek appropriate patent protection for any material unpatented Licensed Technology disclosed in such publication or presentation which the JSC that it reasonably believes is may be patentable. Once such abstracts, manuscripts or presentations have been reviewed and, where applicable, approved by the JSCeach Party, the same abstracts, manuscripts or presentations do not have to be provided again to the JSC other Party for review for a later submission for or publication. Each Party also shall have the right to require that any of its Confidential Information that is disclosed in any such proposed publication or presentation be deleted prior to such publication or presentation. In any permitted publication or presentation by a Party, the other Party’s contribution shall be duly recognized, and co-authorship shall be determined in accordance with customary industry standards.

Publications and Presentations. The Parties acknowledge that scientific publications must be strictly monitored to prevent any adverse effect from premature publication or dissemination of results of the activities hereunder. Except as required by Applicable Laws, each Party agrees that it shall not publish or present, or permit to be published or presented, the results of the Research Program, Development Program or the Development of a Candidate or the Commercialization of a ProductCollaboration Product or Collaboration Service, including, including but not limited to, studies or clinical trials carried out by such Party as part of the CollaborationCollaboration under this Agreement, without the prior review by and the approval of the JSC in accordance with Section 2.1other Party. Each Party shall provide to the JSC other Party the opportunity to review any of the submitting Party’s proposed abstracts, manuscripts or presentations (including information to be presented verbally) which relate to the Research Program, Development Program or the Development of a Candidate or the Commercialization of a Collaboration Product or Collaboration Service at least [*****] thirty (30) days prior to its intended presentation or submission for publication, and such submitting Party agrees, upon written request from the TSC other Party within such [*****] thirty (30) day period, not to submit such abstract or manuscript for publication or to make such presentation until the other Party is given up to [*****] sixty (60) days from the date of such written request to seek appropriate patent protection for any material in such publication or presentation which the JSC other Party reasonably believes is patentable. Once such abstracts, manuscripts or presentations have been reviewed by the JSCother Party, the same abstracts, manuscripts or presentations do not have to be provided again again, to the JSC either Party for review for a later submission for publication. Each Party also shall have the right to require that its Confidential Information that is disclosed in any such proposed publication or presentation be deleted prior to such publication or presentation. In any permitted publication or presentation by a Party, the other Party’s contribution shall be duly recognized, recognized and co-authorship shall be determined in accordance with customary industry standards. Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Company’s application requesting confidential treatment under Rule 406 of the Securities Act.

Publications and Presentations. The Parties acknowledge that scientific publications and presentations must be strictly monitored to prevent any adverse effect from premature publication or dissemination of results of the activities hereunder. Except Each Party agrees that, except as required by Applicable Laws, each Party agrees that it shall not publish or present, or permit to be published or presented, the results of the Research Program, Program or the Development of a Candidate or the Commercialization of a Product, including, but not limited to, studies Licensed Product to the extent such results refer to or clinical trials carried out by such Party as part of otherwise relate to the Collaboration, Licensed Technology or Licensed Patent Rights (the “Covered Results”) without the prior review by and the approval of the JSC in accordance with Section 2.1other Party. Each Party shall provide to the JSC other Party the opportunity to review any each of the submitting Party’s proposed abstracts, manuscripts or presentations (including including, without limitation, information to be presented verbally) which that relate to the Research Program, the Development of a Candidate or the Commercialization of a Product Covered Results at least [*****] days prior to its intended presentation or submission for publication, and such submitting Party agrees, upon written request from the TSC other Party given within such [*****] day period], not to submit such abstract or manuscript for publication or to make such presentation until the other Party is given up to [*****] days from the date of such written request to seek appropriate patent protection for any material Covered Rights in such publication or presentation which the JSC that it reasonably believes is may be patentable. Once such abstracts, manuscripts or presentations have been reviewed and approved by the JSCeach Party, the same abstracts, manuscripts or presentations do not have to be provided again to the JSC other Party for review for a later submission for publication. Each Party also shall have the right to require that any of its Confidential Information that is disclosed in any such proposed publication or presentation be deleted prior to such publication or presentation. In any permitted publication or presentation by a Party, the other PartyPortions of this Exhibit, indicated by the xxxx “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s contribution shall be duly recognizedapplication requesting confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, and co-authorship shall be determined in accordance with customary industry standardsas amended.

Publications and Presentations. The Parties acknowledge that scientific publications and presentations must be strictly monitored to prevent any adverse effect from premature publication or dissemination of results of the activities hereunder. Except Each Party agrees that, except as required by Applicable Laws, each Party agrees that it shall not publish or present, or permit to be published or presented, the results of the Research Program, Program or the Development of a Candidate or the Commercialization of a Product, including, but not limited to, studies or clinical trials carried out by such Party as part of the Collaboration, Program without the prior review by and the written approval of the JSC in accordance with Section 2.1other Party. Each Party shall provide to the JSC other Party the opportunity to review any each of the submitting Party’s proposed abstracts, manuscripts or presentations (including including, without limitation, information to be presented verbally) which that relate to the Research Program, Program or the Development of a Candidate or the Commercialization of a Product Program at least [* (*****] ) days prior to its intended presentation or submission for publication, and such submitting Party agrees, upon written request from the TSC other Party given within such [* (*****] ) day period, not to submit such abstract or manuscript for publication or to make such presentation until the other Party is given up to [* (*****] ) days from the date of such written request to seek appropriate patent protection for any material in such publication or presentation which the JSC that it reasonably believes is may be patentable. Once such abstracts, manuscripts or presentations have been reviewed and approved by the JSCeach Party, the same abstracts, manuscripts or presentations do not have to be provided again to the JSC other Party for review for a later submission for publication. Each Party also shall have the right to require that any of its Confidential Information that is disclosed in any such proposed publication or presentation be deleted prior to such publication or presentation. In any permitted publication or presentation by a Party, the other Party’s contribution shall be duly recognized, and co-authorship shall be determined in accordance with customary industry standards. Each Party (a) expressly acknowledges that the other Party’s business may be substantially dependent on its ability to publish results in scientific journals, presentation at scientific conferences and meetings and (b) agrees that it shall not unreasonably withhold, condition or delay its consent to any request by the other Party to publish results of the Research Program or any Development Program in accordance with its internal publication guidelines.

Publications and Presentations. The Parties acknowledge that scientific publications and presentations must be strictly monitored to prevent any adverse effect from premature publication or dissemination of results of the activities hereunder. Except Each Party agrees that, except as required by Applicable Laws, each Party agrees that it shall not publish or present, or permit to be published or presented, the results of the Research Program, the Development of a Candidate or the Commercialization of a Product, including, but not limited to, studies Licensed Product to the extent such results refer to or clinical trials carried out by such Party as part of otherwise relate to the Collaboration, Licensed Technology or Licensed Patent Rights (the “Covered Results”) without the prior review by and the approval of the JSC in accordance with Section 2.1other Party. Each Party shall provide to the JSC other Party the opportunity to review any each of the submitting Party’s proposed abstracts, manuscripts or presentations (including including, without limitation, information to be presented verbally) which that relate to the Research Program, the Development of a Candidate or the Commercialization of a Product Covered Results at least [***] ([**] *]) days prior to its intended presentation or submission for publication, and such submitting Party agrees, upon written request from the TSC other Party given within such [***]-[***] day period, not to submit such abstract or manuscript for publication or to make such presentation until the other Party is given up to [***] ([**] *]) days from the date of such written request to seek appropriate patent protection for any material Covered Rights in such publication or presentation which the JSC that it reasonably believes is may be patentable. Once such abstracts, manuscripts or presentations have been reviewed and approved by the JSCeach Party, the same abstracts, manuscripts or presentations do not have to be provided again to the JSC other Party for review for a later submission for publication. Each Party also shall have the right to require that any of its Confidential Information that is disclosed in any such proposed publication or presentation be deleted prior to such publication or presentation. In any permitted publication or presentation by a Party, the other Party’s contribution shall be duly recognized, and co-authorship shall be determined in accordance with customary industry standards.

Publications and Presentations. The Parties acknowledge that scientific publications and presentations must be strictly monitored to prevent any adverse effect from premature publication or dissemination of results of the activities hereunder. Except Each Party agrees that, except as required by Applicable Laws, each Party agrees that it shall not publish or present, or permit to be published or presented, the results of the Research Program, Program or the Development of a Candidate or the Commercialization of a Product, including, but not limited to, studies Licensed Product to the extent such results refer to or clinical trials carried out by such Party as part of otherwise relate to the Collaboration, Licensed Technology or Licensed Patent Rights (the “Covered Results”) without the prior review by and the approval of the JSC in accordance with Section 2.1other Party. Each Party shall provide to the JSC other Party the opportunity to review any each of the submitting Party’s proposed abstracts, manuscripts or presentations (including including, without limitation, information to be presented verbally) which that relate to the Research Program, the Development of a Candidate or the Commercialization of a Product Covered Results at least [*****] days prior to its intended presentation or submission for publication, and such submitting Party agrees, upon written request from the TSC other Party given within such [*****] day period], not to submit such abstract or manuscript for publication or to make such presentation until the other Party is given up to [*****] days from the date of such written request to seek appropriate patent protection for any material Covered Rights in such publication or presentation which the JSC that it reasonably believes is may be patentable. Once such abstracts, manuscripts or presentations have been reviewed and approved by the JSCeach Party, the same abstracts, manuscripts or presentations do not have to be provided again to the JSC other Party for review for a later submission for publication. Each Party also shall have the right to require that any of its Confidential Information that is disclosed in any such proposed publication or presentation be deleted prior to such publication or presentation. In any permitted publication or presentation by a Party, the other Party’s contribution shall be duly recognized, and co-authorship shall be determined in accordance with customary industry standards.

Publications and Presentations. The Parties acknowledge that scientific publications and presentations must be strictly monitored to prevent any adverse effect from premature publication or dissemination of results of the activities hereunder. Except Each Party agrees that, except as required by Applicable Laws, each Party agrees that it shall not publish or present, or permit to be published or presented, the results of the Research Program, research conducted by sanofi-aventis under or pursuant to this Agreement to the Development of a Candidate extent such results refer to or otherwise relate to the Commercialization of a Product, including, but not limited to, studies Licensed Technology or clinical trials carried out by such Party as part of Licensed Patent Rights (the Collaboration, “Covered Results”) without the prior review by and the approval of the JSC in accordance with Section 2.1other Party. Each Party shall provide to the JSC other Party the opportunity to review any each of the submitting Party’s proposed abstracts, manuscripts or presentations (including including, without limitation, information to be presented verbally) which that relate to the Research Program, the Development of a Candidate or the Commercialization of a Product Covered Results at least [***] ([**] *]) days prior to its intended presentation or submission for publication, and such submitting Party agrees, upon written request from the TSC other Party given within such [***]-[***] day period, not to submit such abstract or manuscript for publication or to make such presentation until the other Party is given up to [***] ([**] *]) days from the date of such written request to seek appropriate patent protection for any material Covered Rights in such publication or presentation which the JSC that it reasonably believes is may be patentable. Once such abstracts, manuscripts or presentations have been reviewed and approved by the JSCeach Party, the same abstracts, manuscripts or presentations do not have to be provided again to the JSC other Party for review for a later submission for publication. Each Party also shall have the right to require that any of its Confidential Information that is disclosed in any such proposed publication or presentation be deleted prior to such publication or presentation. In any permitted publication or presentation by a Party, the other Party’s contribution shall be duly recognized, and co-authorship shall be determined in accordance with customary industry standards.

Publications and Presentations. The Parties acknowledge that scientific publications and presentations must be strictly monitored to prevent any adverse effect from premature publication or dissemination of results of the activities hereunder. Except Notwithstanding anything to the contrary contained herein, the right to publish or present, or permit to be published or presented, the results of the Research Program shall be governed by the terms of the Collaborative Research Agreement. Each Party agrees that, except as required by Applicable Laws, each Party agrees that it shall not publish or present, or permit to be published or presented, the results of the Research Program, the Development of a Candidate or the Commercialization of a Product, including, but not limited to, studies or clinical trials carried out by such Party as part of the Collaboration, Program without the prior review by and the approval of the JSC in accordance with Section 2.1other Party. Each Party shall provide to the JSC other Party the opportunity to review any each of the submitting Party’s proposed abstracts, manuscripts or presentations (including including, without limitation, information to be presented verbally) which that relate to the Research Program, the Development of a Candidate or the Commercialization of a Product Program at least [* (*****] ) days prior to its intended presentation or submission for publication, and such submitting Party agrees, upon written request from the TSC other Party given within such [* (*****] ) day period, not to submit such abstract or manuscript for publication or to make such presentation until the other Party is given up to [* (*****] ) days from the date of such written request to seek appropriate patent protection for any material in such publication or presentation which the JSC that it reasonably believes is may be patentable. In the event that the Parties disagree on a proposed publication or presentation, they will discuss the matter in good faith and ARQULE shall have the right to make the final decision on publication or presentation of the results of the Research Program and DS shall have the right to make the final decision on publication or presentation of the results of the Development Program. Once such abstracts, manuscripts or presentations have been reviewed published or presented by the JSCeach Party in accordance with this Section 5.3, the same abstracts, manuscripts or presentations do not have to be provided again to the JSC other Party for review for a later submission for publication. Each Party also shall have the right to require that any of its Confidential Information that is disclosed in any such proposed publication or presentation be deleted prior to such publication or presentation, provided that ARQULE shall be permitted to use data generated by ARQULE and information about AKT in any such publication or presentation. In any permitted publication or presentation by a Party, the other Party’s contribution shall be duly recognized, and co-authorship shall be determined in accordance with customary industry standards. Each Party expressly acknowledges that the other Party’s business may be substantially dependent on its ability to publish results in scientific journals, presentation at scientific conferences and meetings.

Publications and Presentations. The Parties acknowledge that scientific publications and presentations must be strictly monitored to prevent any adverse effect from premature publication or dissemination of results of the activities hereunder. Except Each Party agrees that, except as required by Applicable Laws, each Party agrees that it shall not publish or present, or permit to be published or presented, the results of the Research Program, the Development of a Candidate or the Commercialization of a Product, including, but not limited to, studies Licensed Product to the extent such results refer to or clinical trials carried out by such Party as part of otherwise relate to the Collaboration, Licensed Technology or Licensed Patent Rights (the “Covered Results”) without the prior review by and the approval of the JSC in accordance with Section 2.1other Party. Each Party shall provide to the JSC other Party the opportunity to review any each of the submitting Party’s proposed abstracts, manuscripts or presentations (including including, without limitation, information to be presented verbally) which that relate to the Research Program, the Development of a Candidate or the Commercialization of a Product Covered Results at least [***] ([**] *]) days prior to its intended presentation or submission for publication, and such submitting Party agrees, upon written request from the TSC other Party given within such [*****] day period, not to submit such abstract or manuscript for publication or to make such presentation until the other Party is given up to [***] ([**] *]) days from the date of such written request to seek appropriate patent protection for any material Covered Rights in such publication or presentation which the JSC that it reasonably believes is may be patentable. Once such abstracts, manuscripts or presentations have been reviewed and approved by the JSCeach Party, the same abstracts, manuscripts or presentations do not have to be provided again to the JSC other Party for review for a later submission for publication. Each Party also shall have the right to require that any of its Confidential Information that is disclosed in any such proposed publication or presentation be deleted prior to such publication or presentation. In any permitted publication or presentation by a Party, the other Party’s contribution shall be duly recognized, and co-authorship shall be determined in accordance with customary industry standards.